ClinicalTrials.Veeva

Menu

High-dose Accelerated Theta Burst Stimulation for the Treatment of Alcohol Addiction (TBA)

B

Berthold Langguth, MD, Ph.D.

Status

Enrolling

Conditions

Alcohol Dependence

Treatments

Device: high-dose accelerated intermittent theta burst stimulation
Device: sham high-dose accelerated intermittent theta burst stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT05738174
23-3261-101

Details and patient eligibility

About

This is a two-arm randomized placebo-controlled trial in which 72 patients with alcohol addiction are treated with high-dose accelerated intermittent theta burst stimulation (TBS).

Enrollment

72 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • alchohol dependence according to ICD-10 (F10.2)
  • desire to reduce or abstain from alcohol drinking
  • male or female
  • 18-65 years
  • residency in Germany, German speaking
  • written informed consent

Exclusion criteria

  • contraindications for transcranial magnetic stimulation (electric devices or metal parts in the body such as pacemaker)
  • relevant neurological or internistic diseases according to study investigator
  • treatment with TMS in the past
  • participation in other trials during treatment
  • pregnancy or breatfeeding
  • positive breath test for alcohol
  • legal care and placement in a psychiatric hospital
  • co-medication with disulfiram, acamprosate, topiramate, baclofen, naltrexone, or nalmefene
  • acute psychiatric comorbidity that requires inpatient treatment or medication readjustment (<1 month)
  • severe chronic psychiatric illness (schizophrenia, schizoaffective disorder, bipolar disorder)
  • patients who are unable to complete study questionnaires or follow-up questionnaires (in the opinion of the investigators)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

72 participants in 2 patient groups

intermittent theta burst stimulation (iTBS)
Experimental group
Description:
1200 pulses of iTBS per session with five sessions per day applied at five days (Monday-Friday) with 120% resting motor threshold
Treatment:
Device: high-dose accelerated intermittent theta burst stimulation
sham treatment
Sham Comparator group
Description:
1200 pulses of iTBS per session with five sessions per day applied at five days (Monday-Friday) with 120% resting motor threshold with angled coil
Treatment:
Device: sham high-dose accelerated intermittent theta burst stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Martin Schecklmann, Prof.; Johannes Huebner

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems